MKI67 and neoplasm: Consistently, the triple drug combination significantly downregulated the tumor grade (Fig 7E) and reduced the proliferative index compared to vehicle and single agents as determined by the percentage of Ki‐67‐positive cells, although we did not detect a significant difference of Ki‐67 positivity by the triple and dual drug regimens (Fig 7F).